Summary of Product Characteristics
last updated on the eMC:
02/02/2012
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 02/02/2012 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 4.1 - Therapeutic indications
-
Change to section 4.6 - Pregnancy and Lactation
-
Change to section 5.3 - Preclinical Safety Data
|
|
Updated on 26/07/2011 and displayed until 02/02/2012
|
Reasons for adding or updating:
|
-
Change to section 4.6 - Pregnancy and Lactation
-
Change to section 5.3 - Preclinical Safety Data
|
|
Updated on 21/12/2010 and displayed until 26/07/2011
|
Reasons for adding or updating:
|
-
Change to section 4.1 - Therapeutic indications
-
Change to section 4.2 - Posology and method of administration
|
|
Updated on 30/03/2010 and displayed until 21/12/2010
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
-
Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
-
Change to section 10 date of revision of the text
|
|
Updated on 12/03/2008 and displayed until 30/03/2010
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
-
Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
-
Change to section 10 date of revision of the text
|
|
Updated on 20/09/2005 and displayed until 12/03/2008
|
Reasons for adding or updating:
|
-
Change to section 6. 4 - Special Precautions for Storage
|
|
Updated on 22/08/2001 and displayed until 20/09/2005
|
Reasons for adding or updating:
|
-
Correction of spelling/typing errors
|
|
Updated on 11/07/2001 and displayed until 22/08/2001
|
Reasons for adding or updating:
|
|
|
|
Updated on 27/02/2001 and displayed until 11/07/2001
|
Reasons for adding or updating:
|
|
|
|
Updated on 06/09/1999 and displayed until 27/02/2001
|
Reasons for adding or updating:
|
|
|
|
